HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lysine demethylase 5B (KDM5B): A potential anti-cancer drug target.

Abstract
Lysine demethylase 5B (KDM5B) is a histone demethylase identified in 2007, which is responsible for erasing H3K4me2/3 activation marker. It participates in multiple repressive transcriptional complexes around target gene promoters and performs wide regulatory effects on chromatin structure. Until now, there is growing evidence for the oncogenic function of KDM5B. As the H3K4me2/3 residue represents the transcription initiation site of the active transcription gene, and demethylation of H3K4 is associated with transcriptional repression, making it a potential participant in inhibiting the expression of tumor suppressors. Therefore, KDM5B is considered as a promising drug target for cancer therapy, and many medicinal chemists are trying to design and synthesize potent and selective KDM5B inhibitors with the aid of high-throughput screening, structure based drug design, and structure activity relationship studies. This review focuses on the basic biochemical and physiological function of KDM5B and its involved mechanisms in cancers, a comprehensive overview of KDM5B inhibitors is also introduced.
AuthorsYi-Chao Zheng, Jiao Chang, Lin-Chen Wang, Hong-Mei Ren, Jing-Ru Pang, Hong-Min Liu
JournalEuropean journal of medicinal chemistry (Eur J Med Chem) Vol. 161 Pg. 131-140 (Jan 01 2019) ISSN: 1768-3254 [Electronic] France
PMID30343192 (Publication Type: Journal Article, Review)
CopyrightCopyright © 2018 Elsevier Masson SAS. All rights reserved.
Chemical References
  • Antineoplastic Agents
  • Nuclear Proteins
  • Repressor Proteins
  • Jumonji Domain-Containing Histone Demethylases
  • KDM5B protein, human
Topics
  • Antineoplastic Agents (chemical synthesis, chemistry, pharmacology)
  • Drug Screening Assays, Antitumor
  • Humans
  • Jumonji Domain-Containing Histone Demethylases (antagonists & inhibitors, metabolism)
  • Molecular Structure
  • Neoplasms (drug therapy, metabolism)
  • Nuclear Proteins (antagonists & inhibitors, metabolism)
  • Repressor Proteins (antagonists & inhibitors, metabolism)
  • Structure-Activity Relationship

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: